| A Study of Multiple Oral Doses of IX-01 in Healthy Men (NCT01994083) | Ixchelsis Limited | 2013-11-01 |
| Prehabilitation for Prostate Cancer Surgery (NCT02036684) | University of Guelph-Humber | 2013-11-01 |
| Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma (NCT03168035) | NanoCarrier Co., Ltd. | 2013-11-01 |
| Phase I Trial of Cabozantinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT01961765) | Massachusetts General Hospital | 2013-11-01 |
| A Phase 1 Study in Patients With Relapsed or Refractory Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma (NCT01950364) | Millennium Pharmaceuticals, Inc. | 2013-11-01 |
| Safety, Pharmacokinetics and Pharmacodynamics Study With 2B3-201 in Healthy Subjects and Multiple Sclerosis(MS) Patients (NCT02048358) | BBB-Therapeutics B.V. | 2013-11-01 |
| Effect of BI 207127 + Faldaprevir on Blood Levels of Oral Contraceptives Containing Ethinylestradiol and Levonorgestrel (NCT01941615) | Boehringer Ingelheim | 2013-11-01 |
| A Food Effect Phase I Study of the Volitinib in Healthy Subjects (NCT02017236) | Hutchison Medipharma Limited | 2013-11-01 |
| Thorough QT Study of Intravenous Amisulpride (NCT02661594) | Acacia Pharma Ltd | 2013-11-01 |
| A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp When Administered as a Bolus in a Continuous Subcutaneous Infusion Regimen in Subjects With Type 1 Diabetes (NCT01992588) | Novo Nordisk A/S | 2013-11-01 |
| An Interactive Computer Game, Called Duck Duck Punch, for Stroke Rehabilitation at Home and in a Rehabilitation Clinic (NCT02882997) | Medical University of South Carolina | 2013-11-01 |
| A Phase I Study to Assess Cardiac and General Safety and Pharmacokinetics of 60 mg MGN1703 (NCT01982747) | Mologen AG | 2013-11-01 |
| Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer (NCT01890213) | Duke University | 2013-11-01 |
| LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab (NCT01986426) | Lytix Biopharma AS | 2013-11-01 |
| A Single-dose, Randomised, Crossover, Placebo-controlled Study Assessing Two Fixed-dose Combinations of Inhaled Long-acting Beta-agonist and Corticosteroid (NCT02094274) | Almirall, S.A. | 2013-11-01 |
| Effect of Food and Increased Gastric pH Value on Bioavailability of a Single Dose of BI 207127 in Healthy Caucasian and Japanese Subjects (NCT01983566) | Boehringer Ingelheim | 2013-11-01 |
| Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma (NCT01956084) | Catherine Bollard | 2013-11-01 |
| A Blinded, Placebo-Controlled Study of the Safety and Pharmacokinetics of Single Doses of Intravenous Deferiprone in Healthy Volunteers (NCT01989455) | ApoPharma | 2013-11-01 |
| Vitamin D Intervention Trial in Healthy Chinese, Phase II (NCT01998763) | Chinese Academy of Sciences | 2013-11-01 |
| Glutamate, Learning, and Working Memory (NCT02769936) | University of California, Los Angeles | 2013-11-01 |
| Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer (NCT02050178) | OncoMed Pharmaceuticals, Inc. | 2013-11-01 |
| Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination (NCT02007811) | University of Erlangen-Nürnberg Medical School | 2013-11-01 |
| Provoked, Localized Vulvodynia Treatment With Acupuncture and Lidocaine Pilot Study (NCT01996384) | Oregon College of Oriental Medicine | 2013-11-01 |
| A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema (NCT01934556) | Palmetto Retina Center, LLC | 2013-11-01 |
| Phase I, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of an M1 Agonist to Treat Cognitive Impairment (NCT02291783) | Nxera Pharma UK Limited | 2013-11-01 |
| A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04 (NCT01989663) | CONRAD | 2013-11-01 |
| Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation (NCT01983761) | Targazyme, Inc. | 2013-11-01 |
| Phase I Study Evaluating the Safety and Pharmacokinetics of Budesonide, Glycopyrronium, and Formoterol Fumarate Inhalation Aerosol (BGF MDI) in Healthy Volunteers (NCT01980615) | Pearl Therapeutics, Inc. | 2013-11-01 |
| Imaging With 111 Indium (111In)-Pertuzumab (PmAb) to Predict Response to Trastuzumab (TmAb) in Human Epidermal Growth Factor-2 (HER2) Positive Metastatic Breast Cancer (MBC) or Locally Advanced Breast Cancer (LABC) (NCT01805908) | Ontario Clinical Oncology Group (OCOG) | 2013-11-01 |
| Effect of RANKL Inhibition on UV-induced Immunosuppression (NCT01978483) | Innovaderm Research Inc. | 2013-11-01 |
| A Phase 1, First-In-Human Study of Escalating Doses of Oral TVB-2640 in Patients With Solid Tumors (NCT02223247) | Sagimet Biosciences Inc. | 2013-11-01 |
| Study of Pomalidomide, Dexamethasone, and Romidepsin for Rel/Ref Myeloma (NCT01979276) | Weill Medical College of Cornell University | 2013-11-01 |
| Safety and the Pharmacokinetic Study of Characteristics of MKT-N2 (Montelukast) and Singulair® (Montelukast Sodium)to Treat Asthma (NCT02029313) | PharmaKing | 2013-11-01 |
| SABR Including Regional Lymph Node Irradiation for Patients With High Risk Prostate Cancer (SATURN) (NCT01953055) | Sunnybrook Health Sciences Centre | 2013-11-01 |
| Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer (NCT01940172) | TetraLogic Pharmaceuticals | 2013-11-01 |
| MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma (NCT01748721) | Morphotek | 2013-11-01 |
| A Study To Examine The Distribution Of PF-05212377 In The Brain Of Healthy Volunteer Subjects Using Positron Emission Tomography And A Radioactive Tracer Following Oral Administration Of One Dose Of PF-05212377 (NCT02005991) | Pfizer | 2013-11-01 |
| To Assess the Effect of Food on the Pharmacokinetics of Selumetinib (AZD6244; ARRY-142886) (Hyd-Sulfate) in Healthy Male Volunteers (NCT01974349) | AstraZeneca | 2013-11-01 |
| A Study to Assess the Pharmacokinetics of Intranasally Administered Esketamine in Healthy Japanese and Caucasian Volunteers (NCT01980303) | Janssen Research & Development, LLC | 2013-11-01 |
| Phase 1 Study on the Safety and Reactogenicity of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) Given Intramuscularly Compared to Standard Trivalent Inactivated Poliovirus Vaccine (IPV) in Healthy Adults (NCT01997632) | University Hospital, Ghent | 2013-11-01 |
| Phase I Ascending Multiple-Dose Study of BMS-986115 in Subjects With Advanced Solid Tumors (NCT01986218) | Bristol-Myers Squibb | 2013-11-01 |
| Study to Assess Bioequivalence of 30 and 120 mg Nifurtimox Tablets in Chronic Chagas' Patients (NCT01927224) | Bayer | 2013-11-01 |
| Effectiveness of Chemotherapy in Metastatic or Recurrent Carcinoma Cervix (NCT02492503) | All India Institute of Medical Sciences | 2013-11-01 |
| Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck (NCT02075112) | Emory University | 2013-11-01 |
| Two-way Crossover Study in Healthy Male and Female Subjects to Evaluate the Bioequivalence of Jentadueto®. (NCT01947153) | Boehringer Ingelheim | 2013-11-01 |
| A Study of LY2801653 in Healthy Participants (NCT01981408) | Eli Lilly and Company | 2013-11-01 |
| Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma (NCT01991938) | Verastem, Inc. | 2013-11-01 |
| Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA) (NCT01971281) | NovoCure Ltd. | 2013-11-01 |
| Tocilizumab in the Management of Juvenile Idiopathic Arthritis Associated Uveitis (NCT01603355) | Eric B. Suhler | 2013-11-01 |
| A Single Ascending Dose Study Investigating the Safety, Pharmacokinetics and Pharmacodynamics of RO6836191 in Healthy Male Volunteers. (NCT01995383) | Hoffmann-La Roche | 2013-11-01 |
| Bioavailability of ABT-333 Within the Gastrointestinal Tract in Healthy Subjects (NCT02052349) | AbbVie | 2013-11-01 |
| Dyadic Therapy for Mothers and Children (NCT02123160) | New York State Psychiatric Institute | 2013-11-01 |
| A Phase I, Bioequivalence Study to Evaluate Two Formulations of Bendamustine (BDM) Hydrochloride (HCl) Administered to Cancer Patients (NCT02162888) | Eagle Pharmaceuticals, Inc. | 2013-11-01 |
| A Phase 1 Ascending Dose Study to Assess the Safety and Immunogenicity of Adenovirus Anthrax Vector Candidate Vaccines (NCT01979406) | Emergent BioSolutions | 2013-11-01 |
| Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase Ib Study in Chronic Hepatitis B Patients (NCT01997944) | Beijing Bio-Fortune Ltd. | 2013-11-01 |
| Expanded Use PK of Dapivirine Vaginal Ring (NCT01952561) | International Partnership for Microbicides, Inc. | 2013-11-01 |
| Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis (NCT02029066) | G&E Herbal Biotechnology Co., LTD | 2013-11-01 |
| Lesinurad Tablet Relative Bioavailability (NCT01986556) | Ardea Biosciences, Inc. | 2013-11-01 |
| Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza (NCT02014649) | Biota Scientific Management Pty Ltd | 2013-11-01 |
| Physical Conditioning and Decitabine for Newly Diagnosed AML Patients Age ≥ 60 (NCT02234037) | Emory University | 2013-11-01 |
| Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Single and 14 Day Repeat Topical Application of GSK1940029 (NCT01938482) | GlaxoSmithKline | 2013-10-31 |
| Single Rising Dose Study of MK-8723 in Healthy Participants and Participants With Immune Thrombocytopenia Purpura (MK-8723-001) (NCT01963260) | Merck Sharp & Dohme LLC | 2013-10-31 |
| Japanese Phase 1 Trial of Sym004 in Solid Tumors (NCT01955473) | Merck KGaA, Darmstadt, Germany | 2013-10-31 |
| Single and Multiple Dose Study of Uprifosbuvir (MK-3682/IDX21437) in Healthy and Hepatitis C Virus (HCV)-Infected Participants (MK-3682-001) (NCT01974687) | Merck Sharp & Dohme LLC | 2013-10-31 |
| A Comparative Bioavailability Study of Lomitapide 20 mg Intact vs Sprinkled (NCT02044419) | Aegerion Pharmaceuticals, Inc. | 2013-10-30 |
| A Study to Evaluate the Irritation Potential of GSK2894512 Cream on Skin in Healthy Subjects (NCT01984775) | Stiefel, a GSK Company | 2013-10-30 |
| Safety, Tolerability and PK of Intravenous (IV) ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers (NCT01952444) | Elusys Therapeutics | 2013-10-29 |
| Study of Safety and Effectiveness of Intravenous Immunization With PfSPZ Vaccine in Healthy African Adults (NCT01988636) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-10-29 |
| Oprozomib and Dexamethasone,in Combination With Lenalidomide or Oral Cyclophosphamide to Treat Newly Diagnosed Multiple Myeloma (NCT01881789) | Amgen | 2013-10-28 |
| Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery (NCT01912625) | National Cancer Institute (NCI) | 2013-10-28 |
| Vosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based Therapy (NCT01980056) | Weill Medical College of Cornell University | 2013-10-25 |
| This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood Samples (NCT01957189) | GlaxoSmithKline | 2013-10-25 |
| A Phase 1b Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung Cancer (NCT02000947) | MedImmune LLC | 2013-10-25 |
| Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS). (NCT01835587) | Celgene | 2013-10-25 |
| A Study of Nivolumab by Itself or Nivolumab Combined With Ipilimumab in Patients With Advanced or Metastatic Solid Tumors (NCT01928394) | Bristol-Myers Squibb | 2013-10-24 |
| Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma (NCT01849146) | National Cancer Institute (NCI) | 2013-10-24 |
| Darapladib China PK (NCT02000804) | GlaxoSmithKline | 2013-10-23 |
| Phase I/II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Metastatic Colorectal Cancer (NCT01896856) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-10-23 |
| A Study to Evaluate the Safety and Use of Human Rhinovirus in Healthy and Asthmatic Participants (MK-0000-218) (NCT01866306) | Merck Sharp & Dohme LLC | 2013-10-22 |
| Open Dose Escalating Trial to Determine the Maximum Tolerated Dose in Paediatric Patients With Advanced Cancers for Whom no Therapy is Known (NCT01971476) | Boehringer Ingelheim | 2013-10-22 |
| A Safety Study of SGN-LIV1A in Breast Cancer Patients (NCT01969643) | Seagen Inc. | 2013-10-22 |
| Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer (NCT01872260) | Novartis Pharmaceuticals | 2013-10-22 |
| A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas (NCT01837862) | Julie Krystal | 2013-10-22 |
| A Study of Decitabine (DACOGEN) in Sequential Administration With Cytarabine in Children With Relapsed or Refractory Acute Myeloid Leukemia (NCT01853228) | Janssen Research & Development, LLC | 2013-10-22 |
| Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis (NCT01986920) | Aclaris Therapeutics, Inc. | 2013-10-22 |
| A Study to Assess the Bronchodilator Effect of a Single Dose of Fluticasone Furoate (FF)/ Vilanterol (VI) 100/25 Micrograms (mcg) Combination When Administered in Adult Patients With Asthma (NCT01837316) | GlaxoSmithKline | 2013-10-21 |
| Olaparib and Radiotherapy in Inoperable Breast Cancer (NCT02227082) | The Netherlands Cancer Institute | 2013-10-21 |
| Study to Evaluate the Pharmacokinetic Profile of Salbutamol Delivered by Unit Dose Dry Powder Inhaler (UD-DPI) Compared to the Diskus and Metered Dose Inhaler (MDI) in Healthy Volunteers. (NCT01984086) | GlaxoSmithKline | 2013-10-21 |
| A Phase 1 QT Study in Healthy Male Subjects (NCT01986894) | Celgene | 2013-10-18 |
| Lenalidomide With or Without Idelalisib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma (NCT01838434) | Alliance for Clinical Trials in Oncology | 2013-10-17 |
| Manganese-Enhanced Magnetic Resonance Imaging in Healthy Volunteers and People With Multiple Sclerosis (NCT01326715) | National Institute of Neurological Disorders and Stroke (NINDS) | 2013-10-17 |
| A Two Part Study of RO6870810. Dose-Escalation Study in Participants With Advanced Solid Tumors and Expansion Study in Participants With Selected Malignancies (NCT01987362) | Hoffmann-La Roche | 2013-10-16 |
| Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma (NCT01833520) | M.D. Anderson Cancer Center | 2013-10-16 |
| Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung Cancer (NCT01967095) | Memorial Sloan Kettering Cancer Center | 2013-10-15 |
| CT Antigen TCR-Engineered T Cells for Myeloma (NCT01892293) | Adaptimmune | 2013-10-15 |
| Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of MK-8666 in Participants With Type 2 Diabetes Mellitus (MK-8666-003) (NCT01971554) | Merck Sharp & Dohme LLC | 2013-10-14 |
| Study to Investigate the Irritation Potential of GSK1940029 Gel (NCT01984801) | GlaxoSmithKline | 2013-10-14 |
| A Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Self-Administered Subcutaneously (SC) by Healthy Subjects (NCT01894360) | GlaxoSmithKline | 2013-10-14 |
| A Phase Ⅰa Study of Remimazolam Tosylate in Healthy Volunteers (NCT01970072) | Jiangsu HengRui Medicine Co., Ltd. | 2013-10-14 |
| Alpha 1 Anti-Trypsin (AAT) in Treating Patients With Acute Graft-Versus-Host Disease GVHD) (NCT01523821) | Fred Hutchinson Cancer Center | 2013-10-11 |